Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Lexicon Pharmaceuticals, Inc. (NQ: LXRX)
2.210 USD  +0.030 (+1.38%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Lexicon Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 Next >
Market Wrap for Monday, April 29: Stocks Start Week With a Rally
April 29, 2013
The S&P 500 traded into record high territory on Monday as the markets started the week off on a strong note. A rally in U.S. stocks was sparked in part by better than expected consumer spending for... Read More
category Earnings , Benzinga , Movers , and 30 more.
from Latest Articles from Benzinga.com
Unusual 11 Mid-Day Movers 04/29: (OSH) (WRLS) (GALT) Higher; (LAS) (NTE) (GWAY) Lower
April 29, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8285869 for the full story. Read More
from StreetInsider.com News Articles
Gain In Consumer Spending Boosts Markets
April 29, 2013
The markets extended its gains during the midday with the Dow soaring 93 points to 14,806 as March consumer spending rose 0.2%. Nasdaq gained 33 points to 3312. Read More
category Market News
from MarketMinute.com Market Updates
Stock to Watch: Lexicon Pharmaceuticals Down 7.0% (LXRX)
April 29, 2013
from Comtex SmarTrend® News Briefs
Lexicon Pharmaceuticals (LXRX) Under Heavy Selling Pressure
April 29, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8285324 for the full story. Read More
from StreetInsider.com News Articles
U.S. FDA approves Johnson & Johnson diabetes drug, canagliflozin
March 29, 2013
March 29 (Reuters) - U.S. health regulators have approved a new diabetes drug from Johnson & Johnson, making it the first in its class to be approved in the United States. Read More
category companyNews
from Reuters: Company News
Lexicon Pharmaceuticals (LXRX) Reports In-Line Q4 EPS
February 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8118879 for the full story. Read More
from StreetInsider.com News Articles
Markets Soar On Fiscal Cliff Deal Optimism
December 31, 2012
Optimism that lawmakers would finalize a deal to avoid the fiscal before the midnight deadline boosted the markets to a sharply higher close with the Dow leaping 166 points to 13,104. Nasdaq jumped 59... Read More
category Market News
from MarketMinute.com Market Updates
Lexicon Granted Fast Track Status
December 31, 2012
The Food and Drug Administration granted Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) fast track status for its LX1033. Shares of the biopharmaceutical rose 30 cents to close at $2.21.... Read More
from MarketMinute.com Stock News
Stocks Surge as Fiscal Cliff Deal Appears Close
December 31, 2012
The U.S. stock market jumped on Monday as Congressional lawmakers suggested that a deal to avert the looming "fiscal cliff" appears to be near at hand. Throughout the day, the market continued to rise... Read More
category Benzinga , Movers , SPY , and 32 more.
from Latest Articles from Benzinga.com
Mid-Day Market Update: Political Indecision Looms, Yet Markets Rise
December 31, 2012
Following the market opening Monday, the Dow traded up 0.32 percent to 12,978.08 while the NASDAQ rose 0.94 percent to 2,988.24. The S&P also rose, increasing 0.63 percent to 1,411.25. Top Headline... Read More
category Benzinga , Movers , Global , and 24 more.
from Latest Articles from Benzinga.com
Unusual 11 Mid-Day Movers 12/31: (UNXL) (DUF) (LXRX) Higher; (EMITF) (CALM) (ZAZA) Lower
December 31, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7974751 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals Up 11.0%, Shares Break Through Resistance (LXRX)
December 31, 2012
from Comtex SmarTrend® News Briefs
Mid-Morning Market Update: Markets Rise Ahead of Fiscal Cliff, Cott Falls
December 31, 2012
Following the market opening Monday, the Dow traded up 0.11 percent to 12,952.08 while the NASDAQ rose 0.68 percent to 2,980.24. The S&P also rose, increasing 0.36 percent to 1,407.25. Top Headline... Read More
category US9295661071 , SVU , Benzinga , and 23 more.
from Latest Articles from Benzinga.com
Lexicon Pharma (LXRX) Hits Two-Month High on Volume
December 31, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7974545 for the full story. Read More
from StreetInsider.com News Articles
8 Biotechnology Stocks to Buy Now
December 19, 2012
 Read More
category NASDAQ:LXRX , NASDAQ:NPSP , NASDAQ:ISIS , and 6 more.
from InvestorPlace - Latest Headlines
Mid-Morning Market Update: Caribou Bought Out; Clearwire Plummets
December 17, 2012
Following the market opening Monday, the Dow traded up 0.41 percent to 13,188.69 while the NASDAQ rose 0.57 percent to 2,988.36. The S&P also rose, increasing 0.63 percent to 1,422.54. Top Headline... Read More
category Earnings , US8317561012 , Benzinga , and 29 more.
from Latest Articles from Benzinga.com
Traders Get Bullish on Shares of Lexicon Pharmaceuticals, Shares Up 7.5% (LXRX)
December 17, 2012
from Comtex SmarTrend® News Briefs
Fiscal Cliff Talks May Reopen, Markets Open Higher
December 17, 2012
The markets opened higher with the Dow gaining 51 points to 13,186 as Republican House Speaker John Boehner indicated a new stance on taxes for the wealthy which may reopen negotiations to address the... Read More
category Market News
from MarketMinute.com Market Updates
StreetInsider.com Pre-Open Movers 12/17: (CBOU) (ENZN) (LXRX) Higher; (CLWR) (SQNM) (AG) Lower (more...)
December 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7952388 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharma Shares Rise Following FDA Fast Track Designation for LX1033 for IBS
December 17, 2012
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast... Read More
category Benzinga , US5288721047 , Movers , and 5 more.
from Latest Articles from Benzinga.com
BRIEF-Lexicon Pharma up in premarket after drug candidate gets fast track status from FDA
December 17, 2012
NEW YORK, Dec 17 (Reuters) - Lexicon Pharmaceuticals Inc : * Lexicon Pharma up 9.1 percent to $2.04 in premarket after drug candidate for irritable bowel syndrome gets fast track status from the U.S.... Read More
category companyNews
from Reuters: Company News
Lexicon's (LXRX) Irritable Bowel Syndrome Drug Receives Fast Track Status
December 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7951640 for the full story. Read More
from StreetInsider.com News Articles
Lexicon (LXRX) Presents Encouraging Data from LX4211 Phase 2b
November 06, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7848321 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals (LXRX) Posts Q3 Loss of 6c/Share
November 06, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7847058 for the full story. Read More
from StreetInsider.com News Articles
Lower Close On Google's Earnings Miss
October 18, 2012
Google's earnings miss weighed the markets down to a lower close with the Dow slipping 8 points to 13,548. Nasdaq tumbled 31 points to 3072. Read More
category Market News
from MarketMinute.com Market Updates
Lexicon Prices Offering At Discount
October 18, 2012
Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) priced its public offering of 17.5 million common shares at the discounted price of $2.25 per share weighing the stock price down 24 cents to close at... Read More
from MarketMinute.com Stock News
Hot Stock: Lexicon Pharmaceuticals, Shares Drop 11.6% (LXRX)
October 18, 2012
from Comtex SmarTrend® News Briefs
Pre-Open Movers 10/18: (GIVN) (SVU) (AEGR) Higher; (ALGN) (MLNX) (IMUC) Lower (more...)
October 18, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7802271 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharma (LXRX) Prices 17.5M Offering at $2.25/Share
October 18, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7802234 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here